Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder

Schizophrenia Research
Vivian MitropoulouLarry J Siever

Abstract

Stress has been associated with the onset of schizophrenia and exacerbation of psychotic symptoms. Patients with schizotypal personality disorder (SPD), the prototypic schizophrenia spectrum disorder, do not develop the frank psychosis of schizophrenia and appear clinically to be less reactive to stress than schizophrenic patients. Schizophrenic patients demonstrate increased dopaminergic (DA) and hypothalamic-pituitary-adrenal-axis (HPA) activation following 2-deoxyglucose (2-DG), an acute metabolic (glycopyruvic) stressor, compared to healthy volunteers (HV). We hypothesized that SPD patients would demonstrate comparable or lower DA and HPA responses after 2-DG to HV. Fifteen SPD patients and 13 HV were administered 2-DG (40 mg/kg, i.v.) in a double-blind, placebo-controlled, randomized protocol. The area under the curve (AUC) was determined for plasma HVA, ACTH and cortisol (utilizing baseline and post infusion indices). 2-DG induced significant increases in ACTH, cortisol and HVA concentrations in both groups and cortisol elevations were significantly lower in patients with SPD than in HV. Patients with SPD have a blunted cortisol and a normal dopaminergic response to 2-DG. These results are consistent with the hypothesis t...Continue Reading

References

Jun 1, 1989·The Journal of Nervous and Mental Disease·J H Reich
Jan 1, 1985·Schizophrenia Bulletin·L J Siever
Sep 1, 1973·Journal of Neurochemistry·R W HortonH S Bachelard
Dec 1, 1993·Hospital & Community Psychiatry·A BreierW T Carpenter
May 1, 1997·The American Journal of Psychiatry·S E RoitmanL J Siever
Feb 10, 2000·Journal of Psychopharmacology·M Laruelle, A Abi-Dargham
Dec 21, 2000·Current Psychiatry Reports·R M Kirrane, L J Siever
Aug 29, 2001·Development and Psychopathology·E F WalkerF Reynolds
Feb 21, 2002·Schizophrenia Research·Larry J SieverMonte Buchsbaum
Sep 30, 2003·Journal of Psychopharmacology·Igor ElmanAlan Breier

❮ Previous
Next ❯

Citations

Apr 14, 2006·Schizophrenia Bulletin·Hanan TrotmanElaine Walker
Feb 16, 2010·Journal of Addictive Diseases·Natascha Wilson, Jean Lud Cadet
Feb 19, 2005·Current Psychiatry Reports·Katherine Seeber, Kristin S Cadenhead
Aug 25, 2007·Annual Review of Clinical Psychology·Adrian Raine
Apr 7, 2011·Journal of Personality Disorders·Andrew E SkodolLarry J Siever
Aug 30, 2012·Journal of Personality Disorders·Eran ChemerinskiLarry J Siever
Oct 25, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexandra SolimanAlain Dagher
Nov 28, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·H HoriH Kunugi
Jul 22, 2008·The Psychiatric Clinics of North America·Antonia S NewLarry J Siever
Oct 10, 2013·Psychiatry and Clinical Neurosciences·Tsutomu TakahashiMichio Suzuki
Oct 23, 2012·Psychoneuroendocrinology·Laura W HarrisSabine Bahn
Mar 26, 2013·Schizophrenia Research·F Romo-NavaM E Shenton
Nov 4, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tsutomu TakahashiMichio Suzuki
Jun 15, 2010·Schizophrenia Research·Brendon W KentLarry J Siever
Nov 29, 2012·Schizophrenia Research·Eran ChemerinskiErin A Hazlett
Jan 24, 2009·Schizophrenia Research·Tsutomu TakahashiChristos Pantelis
Jun 12, 2009·Journal of the American Psychoanalytic Association·Larry J Siever, Lissa N Weinstein
Apr 28, 2006·Current Opinion in Psychiatry·Richard J Drake, Shôn W Lewis
Feb 4, 2010·Journal of the American Geriatrics Society·Jules Rosen
Oct 5, 2010·Depression and Anxiety·John C Markowitz
Apr 12, 2019·BMJ : British Medical Journal·Huan SongUnnur A Valdimarsdóttir
Jan 27, 2006·The Cochrane Database of Systematic Reviews·D J SteinS Seedat
Feb 23, 2018·Frontiers in Psychology·Phillip S Kavanagh, Bianca L Kahl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here